Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/obinutuzumab-lowers-nonrenal-lupus-disease-activity-phase-3-2026a10007lh?src=rss
Author :
Publish date : 2026-03-12 10:40:00
Copyright for syndicated content belongs to the linked Source.
